These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20639555)

  • 21. A mixed methods study of HIV-related services in buprenorphine treatment.
    Knudsen HK; Cook J; Lofwall MR; Walsh SL; Studts JL; Havens JR
    Subst Abuse Treat Prev Policy; 2017 Aug; 12(1):37. PubMed ID: 28814313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buprenorphine clinics: an integrated and multidisciplinary approach to treating opioid dependence.
    Marshalek PJ; Sullivan CR
    W V Med J; 2010; 106(4 Spec No):60-3. PubMed ID: 21932755
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of adolescent opioid dependence: no quick fix.
    Fiellin DA
    JAMA; 2008 Nov; 300(17):2057-9. PubMed ID: 18984896
    [No Abstract]   [Full Text] [Related]  

  • 24. Modeling longitudinal changes in buprenorphine treatment outcome for opioid dependence.
    Saleh MI
    Pharmacopsychiatry; 2014 Nov; 47(7):251-8. PubMed ID: 25321188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interim Buprenorphine vs. Waiting List for Opioid Dependence.
    Sigmon SC; Ochalek TA; Meyer AC; Hruska B; Heil SH; Badger GJ; Rose G; Brooklyn JR; Schwartz RP; Moore BA; Higgins ST
    N Engl J Med; 2016 Dec; 375(25):2504-2505. PubMed ID: 28002704
    [No Abstract]   [Full Text] [Related]  

  • 26. Canadian developments. Buprenorphine now approved for the treatment of opiate addiction.
    Garmaise D
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):20, 22. PubMed ID: 16365961
    [No Abstract]   [Full Text] [Related]  

  • 27. Managing opioid addiction with buprenorphine.
    Donaher PA; Welsh C
    Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New drug buprenorphine can treat patients addicted to heroin or prescription pain medications.
    Clark HW
    W V Med J; 2003; 99(1):42. PubMed ID: 12762216
    [No Abstract]   [Full Text] [Related]  

  • 29. Opioid substitution and HIV/AIDS treatment and prevention.
    Kerr T; Wodak A; Elliott R; Montaner JS; Wood E
    Lancet; 2004 Nov 27-Dec 3; 364(9449):1918-9. PubMed ID: 15566992
    [No Abstract]   [Full Text] [Related]  

  • 30. Office-based treatment for opioid addiction achieving goals.
    Kuehn BM
    JAMA; 2005 Aug; 294(7):784-6. PubMed ID: 16105995
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetic interactions between buprenorphine and antiretroviral medications.
    Bruce RD; McCance-Katz E; Kharasch ED; Moody DE; Morse GD
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S216-23. PubMed ID: 17109308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving opioid dependency treatment.
    Swoboda JT
    J Am Board Fam Pract; 2003; 16(2):185-6. PubMed ID: 12665191
    [No Abstract]   [Full Text] [Related]  

  • 33. Office-based practice and opioid-use disorders.
    Clark HW
    N Engl J Med; 2003 Sep; 349(10):928-30. PubMed ID: 12954740
    [No Abstract]   [Full Text] [Related]  

  • 34. Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine.
    McCance-Katz EF; Moody DE; Morse GD; Friedland G; Pade P; Baker J; Alvanzo A; Smith P; Ogundele A; Jatlow P; Rainey PM
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S224-34. PubMed ID: 17109309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of buprenorphine as a substitute treatment for opiate dependence in the Toxicology Clinics--introductory clinical report].
    Radomska M; Pach J; Chrostek Maj J
    Przegl Lek; 2001; 58(4):351-3. PubMed ID: 11450367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine replacement therapy for adolescents with opioid dependence: early experience from a children's hospital-based outpatient treatment program.
    Levy S; Vaughan BL; Angulo M; Knight JR
    J Adolesc Health; 2007 May; 40(5):477-82. PubMed ID: 17448411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public policy statement on buprenorphine for opiate dependence and withdrawal.
    J Addict Dis; 2004; 23(4):116-7. PubMed ID: 15534969
    [No Abstract]   [Full Text] [Related]  

  • 38. A Second Look at ED-initiated Buprenorphine for Opioid Addiction.
    Hawk K
    ED Manag; 2016 Oct; 28(10):113-114. PubMed ID: 29787643
    [No Abstract]   [Full Text] [Related]  

  • 39. In-office opiate treatment "not a panacea": physicians slow to embrace therapeutic option.
    Vastag B
    JAMA; 2003 Aug; 290(6):731-5. PubMed ID: 12915410
    [No Abstract]   [Full Text] [Related]  

  • 40. Potential for abuse of buprenorphine in office-based treatment of opioid dependence.
    Cicero TJ; Inciardi JA
    N Engl J Med; 2005 Oct; 353(17):1863-5. PubMed ID: 16251550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.